Contrast-Enhanced Ultrasound for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
Phase 2
210
about 4.8 years
18+
1 site in PA
What this study is about
This trial is testing if contrast-enhanced ultrasound (CEUS) can help diagnose kidney cancer that has returned after treatment. CEUS may assist in finding and monitoring long-term recurrence of renal cell cancer following cryo or microwave ablation.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Electronic Health Record Review
- 2.Take Sulfur Hexafluoride Lipid Microspheres
- 3.Undergo Computed Tomography
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Diagnostic Agent (Ultrasound Contrast Activity)
topical (Topical Lotion)
Secondary: Improvement of diagnostic imaging using 2D contrast-enhanced ultrasound (CEUS) with magnetic resonance/ computed tomography fusion
imaging
Oncology